Bio Green Med Solution, Inc.
BGMS
$0.94
$0.044.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 710.00% | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 710.00% | -- | -- | -100.00% |
| Cost of Revenue | -37.04% | -93.22% | -96.85% | -- | -74.84% |
| Gross Profit | 114.12% | 101.82% | 96.85% | -- | 74.61% |
| SG&A Expenses | 31.86% | -18.84% | -23.14% | 163.29% | -49.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.38% | -50.94% | -63.90% | 14.87% | -66.09% |
| Operating Income | 40.81% | 54.43% | 63.86% | -15.64% | 65.90% |
| Income Before Tax | 67.38% | 54.41% | 64.13% | 98.12% | 67.36% |
| Income Tax Expenses | -99.58% | -- | 100.49% | -- | 382.94% |
| Earnings from Continuing Operations | 79.98% | 49.51% | 59.53% | 97.25% | 42.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.98% | 49.51% | 59.53% | 97.25% | 42.10% |
| EBIT | 40.81% | 54.43% | 63.86% | -15.64% | 65.90% |
| EBITDA | 41.00% | 54.41% | 63.85% | -15.66% | 65.86% |
| EPS Basic | 97.21% | 97.01% | 99.11% | -- | -- |
| Normalized Basic EPS | 99.73% | 98.93% | -- | -- | -- |
| EPS Diluted | 97.21% | 97.01% | 99.11% | -- | -- |
| Normalized Diluted EPS | 99.73% | 98.93% | -- | -- | -- |
| Average Basic Shares Outstanding | 11,865.71% | 4,178.52% | -- | -- | -- |
| Average Diluted Shares Outstanding | 11,865.71% | 4,178.52% | 4,534.39% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |